Skip to main content
Navigate Up
Sign In
 

Neuromuscular

Clinical Research



If you think you may qualify for one of these studies, please contact Professional Research Assistant (PRA) below for more information.

 

 Content Editor Web Part

 

Search for: (view all)

COMIRB # Title (Please click on the title to see approved advertisement) Principal Investigator PRA
18-1768 Genomic Translation for Amyotrophic Lateral Sclerosis Care (GTAC) Foster, Laura, MD Neurology, Research Partners
303-724-4644
Eligibility and Information
18-2341 A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis Quan, Dianna, MD Neurology, Research Partners
303-724-4644
Eligibility and Information
18-2536 An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness (ADAPT) Quan, Dianna, MD Neurology, Research Partners
303-724-4644
Eligibility and Information
18-2537 Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others (INC-6601) Fridman, Vera, MD Neurology, Research Partners
303-724-4644
Eligibility and Information
19-0772 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients With Generalized Myasthenia Gravis Dixon, Stacy, MD Neurology, Research Partners
303-724-4644
Eligibility and Information
08-0623 Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey Of Patients With Documented Transthyretin (TTR) Mutations Or Wild-Type TTR Amyloidosis Quan, Dianna, MD Neurology, Research Partners
303-724-4644
Eligibility and Information
17-1132 Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis (IBM) – The International IBM Consortium Genetic Study Wicklund, Matthew, MD Neurology, Research Partners
303-724-4644
Eligibility and Information